CNC vs EBS
Centene Corp (CNC) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CNC and EBS stock pages for the full models.
Not investment advice.